Bill Ringo

Mr. Ringo served as the Senior Vice President Strategy and Business Development at Pfizer from 2008-2010. Mr. Ringo currently serves as a Senior Advisor to Barclays Capital and executive in residence at Sofinnova. In addition, Mr. Ringo serves as Chairman of the Board for Sangamo BioSciences, which is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and modification, and holds a Board seat for Onyx Pharmaceuticals, Inc., a biopharmaceutical company committed to improving the lives of people with cancer. Mr. Ringo also serves on the Board of Directors of BioCrossroads, a public-private collaboration of corporate, university, government and entrepreneurial leaders that supports Indiana’s life sciences research and corporate strengths in life sciences while encouraging business development in the region.